Skip to main content
Be The Investor
S&P 500
7,521.26-0.38%
After Hours7,491.47-0.40%
Nasdaq Composite
25,065.87-0.74%
After Hours24,905.49-0.64%
Dow Jones
52,231.89-0.30%
After Hours52,049.82-0.35%
Russell 2000
2,821.38-0.68%
After Hours2,801.77-0.70%
VIX
VIX
19.46-2.31%
Bitcoin
73,649.19-2.13%
Ethereum
2,047.14-4.00%
Solana
82.94-4.18%
Gold
4,030.20-2.05%
Silver
51.23-2.79%
Copper
6.235-1.73%
WTI Crude Oil
86.04-0.93%
US 10-Year Treasury Yield
4.984+2.49%
Home›Stocks›CRSP
OverviewChartNewsFinancialsBusiness ModelCompetitorsStatisticsAnalysisEarningsValuationHoldersOptionsInsidersForecastCompareFAQ

CRISPR Therapeutics AG

CRSP
NASDAQUnited States flagUSReal-Time Price
$45.15USD
-4.89 (-9.77%)Today
$45.56+0.41 (+0.91%)After HoursLast quote · Nov 10, 2026, 5:35 PM ET

Investors Sentoments

Sign in to share your view.

BTI Score

BASIC required or higher

View pricing
BTI Fair Market Cap
Valuation unavailable
Biotechnology
High Risk

CRISPR Therapeutics AG (CRSP) Forecast & Price Targets

Review available CRISPR Therapeutics AG (CRSP) analyst price targets and compare them with earnings and valuation. Analyst targets are separate from BTI scores; missing data is marked unavailable.

CRSP stock forecast and analyst price targets

Analyst price targets estimate possible future share prices. They are separate from BTI scores and fair-value models. The highest and lowest targets describe the provider's range, not the probability of a bull or bear scenario.

CRSP targets — Financial Modeling Prep — price-target-consensus. Target publication dates and investment horizons are not supplied by this feed.
MeasureTarget (USD)Difference from available quote
Highest analyst target110.00+143.6%
Consensus analyst target69.88+54.8%
Lowest analyst target52.00+15.2%

The comparison uses the available quote, which may be delayed. It is not an expected return over a specified period.

How should I evaluate the CRSP forecast?

Compare the targets with reported earnings, cash flow, valuation assumptions and company risks. A price target alone does not determine whether an investment is suitable.